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Still under the effects of Ike and Gustav, two of the worst hurricanes hitting Cuba 
in the last 50 years (Cuba: Hurricane Season 2008, 2009), a group of young 
scientists from the Caribbean island organized the III International Conference 
on Hereditary Ataxias (1-8 October 2008). The conference hosted researchers 
from Austria, Canada, Colombia, Germany, Guatemala, India, Italy, Mexico, 
Portugal, Spain, and UK. The themes discussed covered areas such as 
Biotechnology, Bioinformatics, Genetics, Epidemiology, Neurology, Metabolism, 
Neuroimaging, Pharmacology, Neurophysiology, Neuropathology, and 
Cognition. One striking feature of the meeting was that as the researchers 
fostered their understanding of Neurodegenerative Diseases and Hereditary 
Ataxias, patients and carers were trained by the experts in parallel workshops on 
the management of the clinical outcomes of these disabling disorders.  
 
Why is Cuba interested in Hereditary Ataxias? 
 
In the 1970’s and 80’s, Cuban scientists described a disease known as 
Spinocerebellar Atrophy, the main clinical outcome of which is ataxia (Orozco et 
al., 1989; Valles, Estrada, & Basterrechea, 1978). A form of Ataxia commonly 
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found in Holguín, a province located in North-East Cuba, is characterized 
clinically by impairment in movement control with emphasis on gait, speech, 
limb coordination, and eye movements (Orozco et al., 1989; Orozco, Nodarse, 
Cordovés, & Auburger, 1990). An important characteristic of the disease is its 
early onset, with some cases presenting as early as age 10. Due to the early onset 
and loss of movement control, sufferers become unable to perform a wide range 
of everyday life activities. The prevalence of the disease in Holguín was found to 
be 41.3 per 100,000 (Valles et al., 1978), suggestive of a familial cluster of Ataxia 
in this region which is the largest of Spinocerebellar Ataxia Type-II (SCA-II) 
described to date (Velásquez et al., 2001). Therefore, it is easy to understand why 
Holguín was chosen as the venue to discuss advances on SCA-II and related 
disorders. 
 
What is the picture on Neurodegenerative Diseases in Latin America? 
 
A  suggested mechanism to explain the high prevalence of SCA-II in Holguín is a 
founder effect (Orozco et al., 1989). The founder effect is described as a dramatic 
decrease in genetic diversity caused by the formation of clusters of individuals 
who remain isolated (Templeton, 1979). Orozco et al. (1989) suggested that an 
alternative explanation for the SCA-II of Holguín might be an interaction 
between a mutant gene and unidentified environmental factors. However, Cuba 
is not the only Latin American country where genetic clusters of 
neurodegenerative diseases have been observed. Two further examples are 
Huntington’s disease (HD) in Venezuela (see Wexler et al., 2004; also see Okun & 
Thommim, 2004 for a revision of the early studies) and Alzheimer’s disease (AD) 
in Colombia (Lopera et al., 1997) which are the largest clusters of familial HD and 
AD reported to date. The III International Conference on Hereditary Ataxias 
celebrated in Holguín, offered a suitable scenario wherein different aspects of 
these neurodegenerative diseases may be considered for discussion.  
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Aware of the impact that the study of these clusters would have on the 
understanding of the mechanisms underlying the development of 
neurodegenerative diseases, in 2003 a group of scientists from different countries 
launched the ALFA Euro-Caribbean Network (Red Eurocaribeña de 
Neurociencias, 2009). The ALFA Network was aimed at supporting the advanced 
integral preparation of researchers and academics working on social, clinical, and 
biological aspects of neurodegenerative diseases. The ALFA Network was a 
project funded by the European Union, and it gathered efforts from higher 
education institutions of three European countries (Prof. Sergio Della Sala’s team 
from the University of Edinburgh, United Kingdom, Dr Francisco Wandosell’s 
team from the Autonomous University of Madrid, Spain, and Dr Muriel 
Darnaudéry’s team from the University of Lille 1, France) and three Latin 
American countries (Dr Francisco Lopera’s Neuroscience Group from the 
University of Antioquia, Colombia,  Dr Mitchell Valdés’s  team from the Cuban 
Neuroscience Centre, and Dr Gladys E. Maestre’s team from the University of 
Zulia, Venezuela).  
 
What can the study of familial forms of neurodegenerative diseases offer to 
neuroscience? 
 
The neurodegenerative diseases mentioned above are familial variants of 
diseases which are also known to have sporadic forms. Two important 
differences between sporadic and familial forms of these diseases are (a) the 
pattern of inheritance and (b) their prevalence.  
 
The familial forms of neurodegenerative diseases found in Cuba, 
Colombia and Venezuela, follow specific patterns of familial transmission 
(Mendelian inheritance), whereas, the sporadic forms of these disease do not 
follow such patterns. For example, for the familial AD found in Colombia, the 
pattern is autosomic dominant, that is at least 50% of offspring will inherit the 
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genetic defect (i.e. will be carriers). It is worth noticing that 100% of the carriers 
will develop AD. Figure 1 illustrates how the genetic defect responsible for the 
development of familial AD found in Colombia spreads across 8 generations. 
 
 
 
Figure 1. Genealogical tree of 13 families (C1 – C13) with E280A associated AD. Filled 
items refer to carriers of the mutation. The diagonal line crossing the items means death. 
Roman numbers are generations and the Arabic numbers are years (see Lopera et al., 
1997 for other family trees and a more thorough description of this disorder). 
 
As to the second difference, the sporadic forms of neurodegenerative 
diseases show a much higher prevalence than familial variants. For example, in 
the case of AD, familial forms show a prevalence of around 0.1% whereas in 
people aged 85 years or older living in the western world the prevalence of 
sporadic AD is between 24% and 33% (Blennow, de Leon, & Zetterberg, 2006). 
Why would it be worth investigating familial variants? I would like to answer 
this question by briefly introducing the work I presented at the III International 
Conference on Hereditary Ataxias held in Holguín, Cuba.  
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My presentation was entitled “ Memory binding deficits as an early 
neurocognitive marker of A lzheimer’s disease: evidence from an early onset 
variant due to the mutation E280A of the Presenilin-1gene” . It is known that 
memory is the earliest function affected by AD. However, it is still unknown 
whether all memory systems are evenly impacted by the disease in its early 
stages. We have recently found that this does not seem to be the case and that 
short-term memory (STM) for objects defined by bound features (e.g., common 
objects with colours) seems to be impacted in AD to a greater extent than other 
forms of non-associative memory (Parra et al., 2009). However, it remains 
unexplored whether this memory impairment can predict familial AD. To this 
aim, we devised a novel task which assesses STM for single and bound 
information (i.e., shapes, colours, or coloured shapes) and assessed with it 
individuals recruited from the Colombian kindred. We assessed asymptomatic 
carriers of the genetic defect E280A, patients in the very early stages of AD, and 
healthy (non-carrier) relatives, who did not have gene defects. We compared 
performance on the novel task with performance in a large neuropsychological 
battery. We found that whereas carriers performed the traditional 
neuropsychological tasks without difficulties, they performed significantly more 
poorly than healthy relatives, but not than AD patients, only in the novel STM 
task (Parra et al., submitted). This suggests that STM binding functions could 
signal the beginning of E280A associated familial AD more effectively than other 
tasks currently used in the assessment of AD. Hence, STM binding may help to 
detect AD earlier than other cognitive functions.  
 
This represents a step forward in the early detection of AD which is one of 
the cardinal strategies for the management and treatment of the disease. 
However, one question that arises from this study is: Could this type of finding 
in familial variants of neurodegenerative diseases be used to make decisions in 
sporadic forms? We do not yet have a clear understanding of the extent to which 
findings in familial variants of neurodegenerative disorders could be used to 
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interpret sporadic forms (Godbolt et al., 2005; Ray, Ashall, & Goate, 1998). 
However, they are valuable insights which prompt actions to investigate similar 
issues in sporadic variants.  
 
Conclusions 
 
My experience in the III International Conference on Hereditary Ataxias, could 
be summarized by three points. First, I learned that interdisciplinary exchanges 
via international collaborations are valuable strategies to create fruitful avenues 
through which biological and social issues underpinning problems affecting 
large populations could be investigated. Second, familial variants of 
neurodegenerative diseases offer promising models to plan sound research 
aimed at devising new methods for detecting these diseases early and acting 
effectively upon their consequences. Third, neuroscience has much to gain from 
developing countries. 
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